Ovid Therapeutics Inc. (OVID)
OVID price $2.45 -0.02 -0.81%
- Ticker
- OVID
- Price
- $2.45
- Change
- -0.02 -0.81%
- Market cap
- $478.48M
- P/E
- -5.15
- Sector
- Healthcare
- Industry
- Biotechnology
Ovid Therapeutics Inc. is a biopharmaceutical firm dedicated to creating significant treatments for individuals and families impacted by neurological disorders across the United States. The company's robust pipeline features several key therapeutic candidates: OV101, a drug candidate currently undergoing Phase 2A clinical trials for Fragile X syndrome; OV329, an inhibitor targeting GABA aminotransferase, aimed at…